New hires:

Merck tapped former GE HealthCare exec Betty Larson as EVP, chief human resources officer, succeeding Steve Mizell.  

Lonza named CDMO Siegfried leader Wolfgang Wienand as its CEO.

Prilenia tapped Jina Swartz, MD, PhD as chief medical officer.

Bayer appointed Sue Ann Pentecost as VP, head of U.S. pharmaceutical communications.

Fractyl Health named Adrian Kimber as chief commercial officer.

Mission 3A appointed Andy Reid as chief operating officer for its healthcare portfolio.

Inizio Evoke appointed Daryl Somma DiSalvo as chief strategy officer.

Odyssey Therapeutics named Julie Clauss as chief operating officer and Christopher Butler as SVP, head of chemistry.

Nxera Pharma tabbed Patrick Branch as head of business development for Japan and APAC.

Tevogen Bio appointed Tapan V Shah as head of investor relations and corporate development.

KBI Biopharma named Peter Carbone as chief quality officer.

Post-acute healthcare provider AccentCare hired Heather Wilson as SVP and head of marketing and communications. 

Doceree named Deepak Kandaswamy as SVP of corporate development and strategy for global growth.

Dr. Marra Francis joined Genece Health as chief medical officer.

AI-powered drug development platform BioPhy named Scott Kobayashi as SVP of sales.

Dyne Therapeutics named Biogen alum John Cox as CEO.

Creative production and channel activation company Tag appointed Brock Hansen as head of localization for the Americas region.

Jaguar Health named Dr. Massimo Radaelli as president of Jaguar International.

Reveleer appointed Alan Tam as chief marketing officer.

Universal Brain announced a host of executive moves in addition to a $3.2 million funding raise.

Gain Therapeutics added Jonas Hannestad, MD, PhD as chief medical officer.

Executive elevations:

Syneos Health U.S. PR promoted Marcie Doser to head of influencer marketing.

Transgene promoted Lucie Larguier to CFO and Christelle Schwoerer to chief human resources officer.

Board appointments:

Autolus Therapeutics announced that Mike Bonney has been appointed as chairman of the board, succeeding John H. Johnson, who stepped down. Additionally, Ravi Rao MD joined as a non-executive director.

Third Harmonic Bio tapped Geoff McDonough, MD to join its board of directors.

RegCell added Steven B. Kanner, PhD, to its board of directors.

Life sciences company Phenovista named Ellen Berg, PhD to its scientific advisory board.

Inventiva nominated Andre Turenne as director on its board.

Sail Biomedicines added Dr. Wendy Chung to its board.

EyePoint Pharmaceuticals expanded its scientific advisory board.


Three executives — Weimin Tang, Gigi Qi Feng and Richard Cheng Li – resigned from I-Mab Biopharma, effective March 31.

See last week’s edition of The Escalator.